Core Insights - NeOnc Technologies Holdings, Inc. reported significant clinical progress and financial results for Q3 2025, highlighting advancements in its CNS oncology pipeline and strategic partnerships [1][5][6] Clinical Pipeline Progress - NEO100-01, an intranasal therapy for malignant recurrent WHO Grade 3/4 IDH1 Astrocytoma, showed a 21% response rate compared to a historical average of less than 8% [3][6] - 44% of patients achieved six-month progression-free survival, significantly higher than the historical range of 21-31% [3][6] - The company secured $2.5 million in STTR grants from NIH to advance NEO212 for gliomas and leukemia, indicating strong scientific validation [3][6] - NuroMENA, the UAE-based subsidiary, established a $50 million strategic partnership with Quazar Investment to enhance collaboration in brain cancer treatment [3][6] Financial Results - General and administrative expenses increased to $903,000 from $244,000 in Q3 2024, attributed to expanded marketing and partnership costs [9] - Research and development expenses decreased to $715,000 from $957,000 in Q3 2024, reflecting active management of trial sites and patient recruitment [9] - The net loss for Q3 2025 was $8.6 million, or $0.45 per diluted share, compared to a net loss of $2.2 million, or $0.12 per diluted share in Q3 2024 [9] Strategic Developments - The company appointed Amir Heshmatpour as CEO to lead the next phase of clinical and corporate growth [3][6] - NeOnc joined the Russell Microcap® Index, increasing visibility among institutional investors [3][6] - The company executed an agreement to acquire advanced AI and 3D bioprinting intellectual property, expanding its technological capabilities [3][6] Upcoming Milestones - Full Phase 2a enrollment for NEO100 has been completed, with top-line data readout expected in May 2026 [3][10] - The final patient cohort in Phase I for NEO212 is on track to complete dosing in 2025 [9][10]

– FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway – ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the third quarter of 2025. Corporate Highlights from 3Q 2025 Announced seco ...

Third Quarter 2025 Highlights XBP Europe Holdings, Inc. (“XBP Europe”) finalized the acquisition of Exela Technologies BPA, LLC (“Exela BPA”) and changed its name to XBP Global Holdings, Inc. on July 29, 2025XBP Europe issued approximately 81.8 million shares for an equity valuation of the combined company of $585.7 million, or $4.98/share Reported revenue1 totaled $209.1 million, a decline of 10.4% year-over-yearCombined Pro Forma Revenue2 totaled $220.4 million, a decline of 18.1% year-over-yearGross marg ...

Core Insights - Treasure Global Inc. has announced a 12-month lock-up for over 51% of its outstanding shares, effective November 14, 2025, indicating strong confidence in its long-term strategy and market stability [1][5][6] Shareholder Commitment - The lock-up involves 24 entities and individuals, collectively representing over 51% of the Company's outstanding shares [2] - Participating shareholders are prohibited from selling, transferring, or disposing of any common stock or convertible securities during the lock-up period, with certain exceptions [3][4] Strategic Alignment - The lock-up is supported by major shareholders, including executive directors and long-standing investors, reflecting confidence in the Company's strategic direction and growth roadmap [5][6] - The CEO emphasized that this alignment allows the Company to execute key initiatives, such as the OXI Wallet and UNIRWA token program, while maintaining a stable shareholder base [6] Growth Initiatives - The lock-up follows significant milestones in the Company's fintech and digital asset initiatives, including the development of the OXI Wallet platform and the UNIRWA token program, showcasing a commitment to long-term growth and innovation [7] - The Company is enhancing its treasury management capabilities to optimize financial resources for growth, supporting sustained value creation [8] Company Overview - Treasure Global is a Malaysia-based technology solutions provider focused on digital transformation in retail and services, with its flagship product being the ZCITY Super App, which has over 2.7 million registered users as of June 2025 [9]

Core Insights - WeShop Holdings Limited has begun trading its Class A ordinary shares on the Nasdaq Capital Market under the ticker symbol "WSHP" and plans to launch its app in the U.S. market [1] - The company has established partnerships with major retailers in the UK, providing access to over 1.2 billion products and achieving over $140 million in sales during its UK pilot [1][5] Company Overview - WeShop is a pioneering social-commerce platform that allows users to earn ownership through shopping, creating a community-owned social shopping network [2][5] - The ShareBack™ Rewards Plan enables users to earn WePoints for shopping and referrals, which can be converted into shares of WeShop [2][5] Market Position - The global e-commerce market is projected to exceed $8 trillion by 2027, with social commerce expected to surpass $2 trillion by 2026, positioning WeShop at the intersection of these trends [3] - WeShop's model promotes a shift from a creator economy to an ownership economy, where every user can become an investor [3] Legal and Advisory Support - Kirkland & Ellis LLP served as U.S. legal counsel, while Harney Westwood & Riegels (BVI) LP acted as BVI counsel, and ThinkEquity provided advisory services for the direct listing [4] Future Plans - WeShop plans to launch its app in the U.S. with partnerships involving hundreds of retailers, further expanding its reach and user engagement [7]

CEDAR PARK, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, today announced that management will participate in the upcoming investor events: Event: Baird 8th Annual Defense & Government ConferenceDate: Tuesday, November 18, 2025Location: The Ritz-Carlton, Tysons Corner, Virginia Event: Deutsche Bank Global Space SummitDate: Wednesday, November 19, 2025Location: Deutsche Bank Center, New York City Event: 14th Annual ROTH Techn ...

Core Insights - Atlantic American Corporation reported a net income of $0.6 million, or $0.02 per diluted share, for Q3 2025, a significant improvement from a net loss of ($2.0) million, or ($0.10) per diluted share, in Q3 2024 [1] - For the nine-month period ended September 30, 2025, net income was $4.7 million, or $0.22 per diluted share, compared to a net loss of ($4.7) million, or ($0.24) per diluted share, in the same period of 2024 [1] - The increase in net income was primarily driven by higher premium revenue in automobile liability, inland marine, and automobile physical damage lines, as well as growth in Medicare supplement and group accident and health lines [1][2] Financial Performance - Operating income increased by $2.3 million in Q3 2025 compared to Q3 2024, and by $7.7 million for the nine-month period [2] - Premium revenue grew nearly 12% year-to-date, supported by new business and solid retention across both property & casualty and life & health segments [3] - Total revenue for Q3 2025 was $53.76 million, up from $44.52 million in Q3 2024, while total revenue for the nine-month period was $159.18 million, compared to $139.18 million in the same period of 2024 [8] Insurance Operations - Insurance premiums for life and health increased to $29.47 million in Q3 2025 from $27.57 million in Q3 2024, and for property and casualty, they rose to $22.5 million from $16.21 million [8] - Insurance benefits and losses incurred for life and health were $17.51 million in Q3 2025, compared to $16.78 million in Q3 2024, while property and casualty incurred losses increased to $17.96 million from $13.98 million [8] Balance Sheet Highlights - Total assets as of September 30, 2025, were $430.86 million, up from $393.43 million at the end of 2024 [9] - Total shareholders' equity increased to $109.49 million from $99.61 million [9] - Book value per common share rose to $5.10 from $4.61 [9]

Core Insights - Embassy Bancorp, Inc. filed its Quarterly Report on Form 10-Q for the period ended September 30, 2025, highlighting its financial performance and operational metrics [1] Company Overview - Embassy Bancorp, Inc. has over $1.7 billion in assets and operates Embassy Bank for the Lehigh Valley, serving the community since 2001 with ten branch locations and a suite of digital banking services [2] - The bank ranks fourth in total deposit market share in Lehigh and Northampton Counties, reinforcing its position as a leading financial institution in the region [3] Financial Performance - Cash and cash equivalents were $108.0 million at September 30, 2025, representing 6.1% of total assets [6] - Total deposits increased by $67.6 million, or 4.4%, to $1.62 billion from $1.55 billion at December 31, 2024 [6] - The bank's net interest margin (FTE) rose to 2.52% for the quarter ended September 30, 2025, up from 2.43% in the previous quarter and 2.21% in the same quarter of the prior year [6] - The cost of funds was 1.82% for the quarter ended September 30, 2025, slightly up from 1.81% in the previous quarter and down from 1.98% in the same quarter of the prior year [6] - The bank's return on average assets increased to 0.87% for the quarter ended September 30, 2025, compared to 0.79% in the previous quarter [6] - Net income for the three months ended September 30, 2025, was $3.8 million, or $0.50 per diluted share, up from $2.7 million, or $0.36 per diluted share, in the same quarter of the prior year [6] Accolades and Recognition - Embassy Bank was named the Reader's Choice "Best Bank" for the 11th consecutive year by The Morning Call and received additional honors for "Best Bank" and "Best Mortgage Company" from Lehigh Valley Style Magazine [4] - Bauer Financial awarded Embassy Bank a 5-star rating, indicating continued financial strength and stability [4]

Press release CROSSJECT completes €5 million financing with Vatel Capital DIJON, France – November 14th, 2025 (8.30 PM CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company that develops products for emergency situations based on its proprietary ZENEO® needle-free auto-injector technology, in the advanced stages of development and registration of ZEPIZURE®, an injectable for the treatment of epileptic seizures, today announces the completion of a €5 million fund raising ...

VANCOUVER, Canada, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or “the Company”) is pleased to announce the closing of the second tranche of its non-brokered private placement, issuing an additional 2,500,000 units at a price of US$0.20 per unit, for gross proceeds of US$500,000.00. Each unit consists of one common share and one-half common share purchase warrant. Each whole warrant entitles the holder to purchase one share of the Company for US$0.30 for a period ...